000 01437 a2200409 4500
005 20250515065216.0
264 0 _c20070927
008 200709s 0 0 eng d
022 _a1099-498X
024 7 _a10.1002/jgm.1045
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcCarthy, Helen O
245 0 0 _aHuman osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
_h[electronic resource]
260 _bThe journal of gene medicine
_cJun 2007
300 _a511-20 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCell Death
650 0 4 _aCell Line, Tumor
650 0 4 _aCytomegalovirus
650 0 4 _aGenetic Therapy
650 0 4 _aGreen Fluorescent Proteins
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasms, Hormone-Dependent
_xenzymology
650 0 4 _aNitric Oxide Synthase Type II
_xgenetics
650 0 4 _aNitrites
_xmetabolism
650 0 4 _aOsteocalcin
_xgenetics
650 0 4 _aPromoter Regions, Genetic
_xgenetics
650 0 4 _aProstatic Neoplasms
_xenzymology
650 0 4 _aTransfection
700 1 _aCoulter, Jonathan A
700 1 _aWorthington, Jenny
700 1 _aRobson, Tracy
700 1 _aHirst, David G
773 0 _tThe journal of gene medicine
_gvol. 9
_gno. 6
_gp. 511-20
856 4 0 _uhttps://doi.org/10.1002/jgm.1045
_zAvailable from publisher's website
999 _c17019508
_d17019508